Published by maria gbaf
Posted on January 27, 2022
The global regenerative medicine (bone and joint) market was valued at US$ 4,254.0 Mn in 2015, and is expected to grow at a year-over-year rate of 13.0% to reach US$ 4,808.9 Mn in 2016. In 2015, North America accounted for the largest revenue share of global regenerative medicine (bone & joints) market, representing a market value of US$ 2,039.8 Mn.
Owing to increasing demand for bone and joint reconstructive surgeries and encouraging government initiatives, North America is expected to remain the largest market for regenerative medicine (bone and joint) in 2016. Europe is the second largest market for regenerative medicine, with the region’s high geriatric population fuelling adoption at a robust pace.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1326
By technology, biomaterials segment accounts for the highest market share globally, owing to favourable reimbursement policies and strong demand for biomaterials. Apart from biomaterials, tissue engineering is the other segment which is quickly gaining traction among end-users, and is projected to witness the highest year-over-year growth among all the technology segments.
On the basis of application, bone graft substitute holds the highest share of the market in terms of value owing to a robust demand of bone graft substitute in orthopaedic treatments. However, complications associated with bone graft substitute can pose challenges to adoption in 2016 and beyond.
While North America and Europe are key to the growth of the regenerative medicine market, rising awareness among healthcare professionals and patients in developing countries of Asia Pacific is expected to open up new opportunities for stakeholders. Favourable government initiatives in growing
Asian economies such as China and India has paved the way for regenerative medicine market in the region. Moreover, adoption in developed countries of APAC, such as Japan and South Korea is also fuelling the growth of the market.
Key participants in the global regenerative medicine market are: Medtronic, Inc. (INFUSE Bone Graft), DePuy Synthes, Inc. (HEALOS Bone Graft), Orthofix, Inc. (Trinity Evolution), NuVasive, Inc. (Osteocel Plus) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler). The key strategy of these players is to expand globally through distribution agreements, mergers and acquisitions, public-private partnerships and new product development.
For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-1326
Key Segments Covered
The global regenerative medicine (bone and joint) market is segmented as follows:
Regenerative Medicine (Bone and Joint) Market, by Technology
Regenerative Medicine (Bone and Joint) Market, by Application
Regenerative Medicine (Bone and Joint) Market, by Geography
Long-term Outlook: The global regenerative medicine market (bone and joints) is anticipated to increase at a CAGR of 11.1% during the forecast period from 2015 to 2019. North America will remain the largest market throughout the forecast period, whereas Bone Graft Substitutes will continue to hold the largest share in terms of application.
For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-1326
Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Market Reports
GCC Medical Gloves Market: FMI’s extensive analysis on the GCC medical gloves market brings to the fore insights that can help stakeholders identify the opportunities and challenges associated with its expansion until 2026. The report infers that the GCC medical gloves market shall register a strong growth rate during the assessment period.
Carpal Tunnel Release Systems Market: Aligning with the growing preference for minimally invasive surgical procedures, the carpal tunnel release systems market is projected to follow a healthy growth trail, according to FMI’s recent report on the subject. The market is expected to surpass an impressive revenue threshold by 2029.
Guidewires Market: FMI’s recent report on the guidewires market highlights prominent dynamics influencing market growth prospects for the forecast period 2020-2030. It elaborates on the revenue prospects for each segment across prominent geographies for the aforementioned assessment cycle.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/regenerative-medicine-market
Press Release Source: https://www.futuremarketinsights.com/press-release/regenerative-medicine-market
The global regenerative medicine (bone and joint) market was valued at US$ 4,254.0 Mn in 2015, and is expected to grow at a year-over-year rate of 13.0% to reach US$ 4,808.9 Mn in 2016. In 2015, North America accounted for the largest revenue share of global regenerative medicine (bone & joints) market, representing a market value of US$ 2,039.8 Mn.
Owing to increasing demand for bone and joint reconstructive surgeries and encouraging government initiatives, North America is expected to remain the largest market for regenerative medicine (bone and joint) in 2016. Europe is the second largest market for regenerative medicine, with the region’s high geriatric population fuelling adoption at a robust pace.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1326
By technology, biomaterials segment accounts for the highest market share globally, owing to favourable reimbursement policies and strong demand for biomaterials. Apart from biomaterials, tissue engineering is the other segment which is quickly gaining traction among end-users, and is projected to witness the highest year-over-year growth among all the technology segments.
On the basis of application, bone graft substitute holds the highest share of the market in terms of value owing to a robust demand of bone graft substitute in orthopaedic treatments. However, complications associated with bone graft substitute can pose challenges to adoption in 2016 and beyond.
While North America and Europe are key to the growth of the regenerative medicine market, rising awareness among healthcare professionals and patients in developing countries of Asia Pacific is expected to open up new opportunities for stakeholders. Favourable government initiatives in growing
Asian economies such as China and India has paved the way for regenerative medicine market in the region. Moreover, adoption in developed countries of APAC, such as Japan and South Korea is also fuelling the growth of the market.
Key participants in the global regenerative medicine market are: Medtronic, Inc. (INFUSE Bone Graft), DePuy Synthes, Inc. (HEALOS Bone Graft), Orthofix, Inc. (Trinity Evolution), NuVasive, Inc. (Osteocel Plus) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler). The key strategy of these players is to expand globally through distribution agreements, mergers and acquisitions, public-private partnerships and new product development.
For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-1326
Key Segments Covered
The global regenerative medicine (bone and joint) market is segmented as follows:
Regenerative Medicine (Bone and Joint) Market, by Technology
Regenerative Medicine (Bone and Joint) Market, by Application
Regenerative Medicine (Bone and Joint) Market, by Geography
Long-term Outlook: The global regenerative medicine market (bone and joints) is anticipated to increase at a CAGR of 11.1% during the forecast period from 2015 to 2019. North America will remain the largest market throughout the forecast period, whereas Bone Graft Substitutes will continue to hold the largest share in terms of application.
For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-1326
Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Market Reports
GCC Medical Gloves Market: FMI’s extensive analysis on the GCC medical gloves market brings to the fore insights that can help stakeholders identify the opportunities and challenges associated with its expansion until 2026. The report infers that the GCC medical gloves market shall register a strong growth rate during the assessment period.
Carpal Tunnel Release Systems Market: Aligning with the growing preference for minimally invasive surgical procedures, the carpal tunnel release systems market is projected to follow a healthy growth trail, according to FMI’s recent report on the subject. The market is expected to surpass an impressive revenue threshold by 2029.
Guidewires Market: FMI’s recent report on the guidewires market highlights prominent dynamics influencing market growth prospects for the forecast period 2020-2030. It elaborates on the revenue prospects for each segment across prominent geographies for the aforementioned assessment cycle.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/regenerative-medicine-market
Press Release Source: https://www.futuremarketinsights.com/press-release/regenerative-medicine-market
